Carregant...
SUN-416 Ipilimumab Associated Hypophysitis and Thyroiditis
INTRODUCTION Ipilimumab, an anti cytotoxic T lymphocyte associated antigen 4 (CTLA 4) antibody, is approved for use in advanced melanoma based upon survival benefit. Anti CTLA 4 antibodies are associated with a myriad of side effects. CLINICAL CASE A 65 year old male with stage 3A malignant melanoma...
Guardat en:
| Publicat a: | J Endocr Soc |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552704/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-416 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|